RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:636945

Invasive candidiasis

low confidenceDisorder

Also known as: Disseminated candidiasis · Systemic candidiasis

Publications

14,391

Trials

51

Interventional, condition-specific

Researchers

1,136

Distinct authors in sample

Gene link

—

Readiness

3/6

Stages with a signal

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

candidiases, invasive · invasive candidiases · invasive candidiasis

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    14,391 matched papers (7,702 in last 10 years) Source

  3. Phenotype characterisedNot found

    No HPO disease–phenotype associations via Monarch for these Mondo IDs

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationPresent

    3 FDA · 3 EMA designations (3 FDA orphan-indication approvals) — e.g. Rezafungin Source

  6. Interventional trialPresent

    51 matched on ClinicalTrials.gov (3 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

6

Designations · 3 with FDA orphan-indication approval

  • FDA RezafunginCandidemia Invasive Candidiasis · 2016-02-08 · Not FDA Approved for Orphan Indication
  • FDA isavuconazonium sulfateCandidemia Invasive Candidiasis · 2014-10-20 · Not FDA Approved for Orphan Indication
  • FDA Amphotericin B lipid complexInvasive Candidiasis · 1996-06-27 · Not FDA Approved for Orphan Indication
  • EMA FosmanogepixTreatment of invasive candidiasis · 18/07/2022 · PositiveEMA designation
  • EMA IbrexafungerpTreatment of invasive candidiasis · 12/11/2021 · PositiveEMA designation
  • EMA rezafungin acetate (Rezzayo)Treatment of invasive candidiasis · 06/01/2021 · PositiveEMA designation

Sources: FDA OOPD · EMA orphan designations

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

2 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.

  • amphotericin B, deoxycholate drug combination · therapeutic
  • Itraconazole · therapeutic

MyDisease.info · MONDO:0044067

Literature

Is anyone studying this?

14,391

14,391 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

14,391 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

7,702 in the last 10 years · low confidence

Phrase hits: 14,389 · MeSH hits: 19

Open Europe PMC search

Who's working on it?

1,136

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Bassetti M5 papers · 2026

    Department of Health Sciences, University of Genoa, Genoa, Italy.

    Papers in Europe PMC
  2. 02
    Cornely OA4 papers · 2026

    University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. Electronic address: oliver.cornely@uk-koeln.de.

    Papers in Europe PMC
  3. 03
    Li J4 papers · 2026

    Department of Ophthalmology Qilu Hospital of Shandong University Jinan China.

    Papers in Europe PMC
  4. 04
    Liu Y4 papers · 2026

    Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, China.

    Papers in Europe PMC
  5. 05
    Zhang Y4 papers · 2026

    AdventHealth Orlando, FL, USA.

    Papers in Europe PMC
  6. 06
    Bicanic T3 papers · 2026

    Institute of Infection and Immunity, St George's Hospital Medical School, City St George's University of London, London, UK.

    Papers in Europe PMC
  7. 07
    Denning DW3 papers · 2026

    Manchester Fungal Infection Group, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Academic Health Science Centre, Core Technology Facility, Manchester, UK.

    Papers in Europe PMC
  8. 08
    Feng Q3 papers · 2026
    Papers in Europe PMC
  9. 09
    Ha X3 papers · 2026
    Papers in Europe PMC
  10. 10
    He H3 papers · 2026

    Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

51

interventional trials for this specific condition

51 interventional trials matched this specific condition name; 3 currently recruiting in our sample. 180 trials are registered for candidiasis, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 11 September 2026

51 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.2th percentile).

low confidence · 97.2th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

51 interventional trials matched after quoted-phrase search and title/condition post-filter.

Broader category: candidiasis

180

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

20 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 22 · after dedupe 22 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 22 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (22)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Invasive candidiasis — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Invasive candidiasis" OR "Disseminated candidiasis" OR "Systemic candidiasis" OR "candidiases, invasive" OR "invasive candidiases"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Candidiasis, Invasive

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Invasive candidiasis" OR "Disseminated candidiasis" OR "Systemic candidiasis" OR "candidiases, invasive" OR "invasive candidiases" OR "Candidiasis, Invasive"

Interventional trials matched via: both, phrase, mesh (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 51 interventional · 20 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"candidiasis"

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (14391) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-27T19:29:12.920Z